 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              After obtaining the approvals from the members, stock exchanges and other regulatory agencies and after having received the 25% of the initial consideration amount from the subscribers, the Board of Directors of Bal Pharma Ltd at its meeting held on October 20, 2014 has approved the issue and allotment of 13,00,000 warrants to the subscribers on preferential basis, at a conversion price of Rs.62/- per warrant.
Shares of BAL PHARMA LTD. was last trading in BSE at Rs.69.05 as compared to the previous close of Rs. 68.35. The total number of shares traded during the day was 2186 in over 61 trades.
The stock hit an intraday high of Rs. 69.5 and intraday low of 68.5. The net turnover during the day was Rs. 150590.